Angiopoietin-1 Promotes Endothelial Cell Proliferation and Migration Through AP-1-dependent Autocrine Production of Interleukin-8
Overview
Authors
Affiliations
Angiopoietin-1 (Ang-1), ligand for the endothelial cell-specific Tie-2 receptors, promotes migration and proliferation of endothelial cells, however, whether these effects are promoted through the release of a secondary mediator remains unclear. In this study, we assessed whether Ang-1 promotes endothelial cell migration and proliferation through the release of interleukin-8 (IL-8). Ang-1 elicited in human umbilical vein endothelial cells (HUVECs) a dose- and time-dependent increase in IL-8 production as a result of induction of mRNA and enhanced mRNA stability of IL-8 transcripts. IL-8 production is also elevated in HUVECs transduced with retroviruses expressing Ang-1. Neutralization of IL-8 in these cells with a specific antibody significantly attenuated proliferation and migration and induced caspase-3 activation. Exposure to Ang-1 triggered a significant increase in DNA binding of activator protein-1 (AP-1) to a relatively short fragment of IL-8 promoter. Upstream from the AP-1 complex, up-regulation of IL-8 transcription by Ang-1 was mediated through the Erk1/2, SAPK/JNK, and PI-3 kinase pathways, which triggered c-Jun phosphorylation on Ser63 and Ser73. These results suggest that promotion of endothelial migration and proliferation by Ang-1 is mediated, in part, through the production of IL-8, which acts in an autocrine fashion to suppress apoptosis and facilitate cell proliferation and migration.
Wang R, Li H, Xie Z, Huang M, Xu P, Yuan C Sci Adv. 2025; 11(3):eads1796.
PMID: 39813336 PMC: 11734714. DOI: 10.1126/sciadv.ads1796.
Greco G, Agafonova A, Cosentino A, Cardullo N, Muccilli V, Puglia C Molecules. 2024; 29(13).
PMID: 38999055 PMC: 11243179. DOI: 10.3390/molecules29133103.
Adult tissue-specific stem cell interaction: novel technologies and research advances.
Luo X, Liu Z, Xu R Front Cell Dev Biol. 2023; 11:1220694.
PMID: 37808078 PMC: 10551553. DOI: 10.3389/fcell.2023.1220694.
Li T, Wu J, Yu W, Mao Q, Cheng H, Zhang X Oxid Med Cell Longev. 2022; 2022:2333848.
PMID: 35783189 PMC: 9247843. DOI: 10.1155/2022/2333848.
Luxen M, van Meurs M, Molema G Front Immunol. 2022; 13:867625.
PMID: 35634305 PMC: 9136877. DOI: 10.3389/fimmu.2022.867625.